Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
12-14 August, 2025
Not Confirmed
Not Confirmed
17-21 August, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
12-14 August, 2025
Industry Trade Show
Not Confirmed
17-21 August, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
02 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/orexo-to-present-clinical-data-for-ox640-at-the-eaaci-congress-302470705.html
10 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/orexo-announces-positive-data-for-powder-based-intranasal-vaccine-formulated-with-the-amorphox-technology-302425436.html
10 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/orexo-announces-positive-topline-data-from-clinical-study-of-ox640-in-subjects-with-and-without-allergic-rhinitis-302347970.html
17 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/orexo-enters-into-collaboration-with-abera-to-develop-nasal-powder-vaccines-based-on-the-amorphox-technology-302333487.html
25 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/orexo-initiates-new-study-of-ox640-in-participants-with-allergic-rhinitis-302287325.html
24 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/orexo-interim-report-q3-2024-302285685.html
Inspections and registrations
ABOUT THIS PAGE